| William Pierzala, CRNA | |
|
1920 Atherholt Rd, Lynchburg, VA 24501-1104 | |
| (434) 200-3000 | |
| Not Available |
| Full Name | William Pierzala |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 14 Years |
| Location | 1920 Atherholt Rd, Lynchburg, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871124883 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 0024178778 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Centra Health - Lynchburg Gen Hospital | Lynchburg, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centra Medical Group Llc | 4789606088 | 603 |
News Archive
Today, Barretos Cancer Hospital (BCH) in Brazil joined The University of Texas MD Anderson Cancer Center's Sister Institution network. In a signing ceremony at BCH's newly opened Research Institute Against Digestive Cancer (IRCAD-Brazil), MD Anderson provost and executive vice president, Raymond DuBois, M.D., Ph.D., marked the beginning of an alliance that will allow the two institutions to build a number of collaborative research projects and academic interactions.
Case Western Reserve researchers have developed a procedure that restores function to muscles involved in the control of breathing - even when they have been paralyzed for more than a year. The breakthrough offers hope that one day patients with severe spinal cord injuries will be able to breathe again without the assistance of a ventilator.
Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.
Bristol-Myers Squibb Company and Pfizer today announced that the companies are planning to submit an application for regulatory approval of apixaban in Europe for the prevention of venous thromboembolism (VTE) after orthopedic surgery in the first half of 2010.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.
› Verified 3 days ago
| Entity Name | Centra Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649228966 PECOS PAC ID: 4789606088 Enrollment ID: O20051230000147 |
News Archive
Today, Barretos Cancer Hospital (BCH) in Brazil joined The University of Texas MD Anderson Cancer Center's Sister Institution network. In a signing ceremony at BCH's newly opened Research Institute Against Digestive Cancer (IRCAD-Brazil), MD Anderson provost and executive vice president, Raymond DuBois, M.D., Ph.D., marked the beginning of an alliance that will allow the two institutions to build a number of collaborative research projects and academic interactions.
Case Western Reserve researchers have developed a procedure that restores function to muscles involved in the control of breathing - even when they have been paralyzed for more than a year. The breakthrough offers hope that one day patients with severe spinal cord injuries will be able to breathe again without the assistance of a ventilator.
Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.
Bristol-Myers Squibb Company and Pfizer today announced that the companies are planning to submit an application for regulatory approval of apixaban in Europe for the prevention of venous thromboembolism (VTE) after orthopedic surgery in the first half of 2010.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| William Pierzala, CRNA 26480 Rivermont Dr, Abingdon, VA 24211-7202 Ph: (606) 923-6755 | William Pierzala, CRNA 1920 Atherholt Rd, Lynchburg, VA 24501-1104 Ph: (434) 200-3000 |
News Archive
Today, Barretos Cancer Hospital (BCH) in Brazil joined The University of Texas MD Anderson Cancer Center's Sister Institution network. In a signing ceremony at BCH's newly opened Research Institute Against Digestive Cancer (IRCAD-Brazil), MD Anderson provost and executive vice president, Raymond DuBois, M.D., Ph.D., marked the beginning of an alliance that will allow the two institutions to build a number of collaborative research projects and academic interactions.
Case Western Reserve researchers have developed a procedure that restores function to muscles involved in the control of breathing - even when they have been paralyzed for more than a year. The breakthrough offers hope that one day patients with severe spinal cord injuries will be able to breathe again without the assistance of a ventilator.
Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.
Bristol-Myers Squibb Company and Pfizer today announced that the companies are planning to submit an application for regulatory approval of apixaban in Europe for the prevention of venous thromboembolism (VTE) after orthopedic surgery in the first half of 2010.
Microbix Biosystems Inc., a biotechnology company commercializing novel technologies for influenza vaccine manufacturing and livestock semen sexing, in addition to a core business of virology products, today reported financial results for the first quarter of fiscal 2011. For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, a 34% decrease from $1,226,538 for the same period in 2009.
› Verified 3 days ago
Marilyn J. Fisher, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-2300 Fax: 434-200-6490 | |
Jeffrey Grey, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3000 | |
Brooks Tanner Nielsen, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 435-773-3302 | |
Anila Sodhi, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 804-594-2622 Fax: 804-594-0915 | |
Allyson Danielle Brasseur, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3000 | |
William Lee Pearce, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 434-200-3000 | |
Amy M. Merritt, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1901 Tate Springs Rd, Lynchburg, VA 24501 Phone: 804-594-2622 Fax: 804-594-0915 |